1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Rachel Sanborn: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer Induction Durvalumab, Chemotherapy, Radiation - Lung Cancer, Non-small Cell Carcinoma | Phase 2 | Terminated | Rachel Sanborn | 10 | 2020-06-18 | 2024-12-20 |
Lung Neoplasms (1)
Carboplatin (1) · Cisplatin (1) · Drug Therapy (1) · Etoposide (1) · Pemetrexed (1) · Radiation (1) · durvalumab (1) · taxane (1)
United States (1)